Quick-Med Technologies, Inc. and the University of Michigan Sign Patent Licensing Agreement

Quick-Med Technologies, Inc. (OTCBB: QMDT) ("QMT” or the "Company”) is pleased to announce that it has signed a patent license agreement with the University of Michigan ("U-M”) that significantly expands the Company’s MultiStat™ technology – its patented family of compounds for the cosmetic treatment of skin conditions, including chronological aging and photo-aging. The license grants QMT the exclusive right to commercialize important U-M patents in the field of cosmetic products. The Company has been commercializing its MultiStat technology through an exclusive distribution agreement with BASF Corporation. Under the agreement, performance ingredients based on the Company’s patented compounds are formulated and sold to the cosmetics industry. "These patents significantly extend our patent estate in the cosmetics arena,” stated Michael R. Granito, Chairman of Quick-Med Technologies, Inc. "Exclusive rights should give us the ability to strengthen our position in the market,” Mr. Granito added. The Company owns exclusive rights for topical use of the MultiStat compounds for cosmetic and military applications, but previously had non-exclusive patent rights for use of U-M patents in the anti-aging cosmetic arena. The agreement covers the exclusive rights to seven (7) U.S. and numerous foreign patents in cosmetics applications. About MultiStat™ MultiStat is a family of advanced, patented compounds and methods that have shown in numerous academic studies significant benefit in promoting the appearance and maintenance of skin. About Quick-Med Technologies, Inc. Quick-Med Technologies, Inc. is a life sciences company focused on developing broad-based technologies within the healthcare and consumer markets. The Company's two core products under development are the (1) NIMBUS™, a technology employing advanced polymers that can be used in a wide range of applications from advanced wound care to industrial and consumer products; and (2) MultiStatTM family of advanced patented methods and compounds, shown to be effective in skin care applications for cosmetic, military, and medical markets. Quick-Med Technologies, Inc. is listed under the symbol "QMDT" on the OTC Bulletin Board. For additional information, visit Quick-Med Technologies’ website: http://www.quickmedtech.com or email at info@quickmedtech.com For Details, Contact: Natasha A. Sorobey at (561) 208-8259. © 2007 Quick-Med Technologies, Inc. All rights reserved. NIMBUS™ and MultiStat™ are trademarks of Quick-Med Technologies, Inc. All other trademarks are the property of their respective owners. Forward-looking statements (statements which are not historical facts) in this release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. For this purpose, any statements contained in this release that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as "may," "will," "to," "expect," "plan," "believe," "anticipate," "intend," "could," "would," "estimate," and/or "continue" or the negative or other variations thereof or comparable terminology is intended to identify forward-looking statements involve risks and uncertainties, including those risks that are discussed in the Company's filings with the Securities and Exchange Commission ("SEC"), including without limitation its Annual Report on Form 10-KSB, which may be accessed at the SEC's Edgar System at www.sec.gov. The signing of a license agreement with the University of Michigan should not be construed by any means as an indication of the present or future value of the Company or its common stock. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. Unless otherwise required by applicable law, the Company does not undertake, and it specifically disclaims any obligation, to update any forward looking statements to reflect occurrences, developments, unanticipated events or circumstances after the date of such statement.